During the foetal stage, a number of so-called cell programs run that are vital to the development of the foetus. In a study published in Cell Reports, researchers demonstrate that one of these foetal programs appears to protect against acute myeloid leukaemia (AML).
“We have used an experimental mouse model that always results in this type of leukaemia. The interesting thing is that, when we to adult mice added a specific molecular cell program that normally only runs during foetal development, over half did not develop AML,” says the author.
The foetal program that the researchers used consists of the RNA-binding protein LIN28, the normal function of which is to regulate other genes. LIN28 is usually only expressed during foetal development and disappears shortly after birth.
“AML is the result of various cell mutations. In our research model, we can follow the development from the first mutation until the disease is established, something that is impossible to do in humans. Our mouses study shows that LIN28 has a strong prophylactic effect,” says the grad student.
The researchers first examined samples from a large number of patients diagnosed with AML, 98 per cent of whom turned out to have no expression of LIN28 whatsoever. In those who did, the level was very low. To understand more about what happens when LIN28 is activated, the researchers then carried out more in-depth molecular and functional studies using their animal model.
“We could see that, in mice, the molecular foetal cell program protected against disease by colliding with the mechanism that drives AML, which might explain why leukaemia is rare in newborns. Given the robust effect we have demonstrated, it will be interesting to study whether the foetal cell program can be used to prevent disease later in life. That said, one should be aware that it remains to be seen how we can reactive such a program in human cells,” says the senior author.
https://www.cell.com/cell-reports/fulltext/S2211-1247(23)00110-9
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fa-fetal-tumor&filter=22
A fetal tumor suppressor protects against acute myeloid leukemia
- 1,297 views
- Added
Latest News
Tumor infiltration of immun…
By newseditor
Posted 28 May
New light-controlled 'off s…
By newseditor
Posted 28 May
Gene function during embryo…
By newseditor
Posted 28 May
Formation of 3D blood vesse…
By newseditor
Posted 27 May
Liver regeneration during c…
By newseditor
Posted 27 May
Other Top Stories
3D mapping of extracellular pH of single living cells
Read more
Transporting large drug molecules into cells via nanoparticles
Read more
Why doesn't deep-brain stimulation work for everyone?
Read more
A method to watch neurons compute
Read more
Developing universal protein translocation system using bacterial t…
Read more
Protocols
SEMORE: SEgmentation and MO…
By newseditor
Posted 26 May
Spatially resolved lipidomi…
By newseditor
Posted 24 May
Efficient expansion and CRI…
By newseditor
Posted 21 May
Massively parallel in vivo…
By newseditor
Posted 20 May
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Publications
Circadian tumor infiltratio…
By newseditor
Posted 28 May
Kalium channelrhodopsins ef…
By newseditor
Posted 28 May
Double-duty isomerases: a c…
By newseditor
Posted 28 May
Signal switching may enhanc…
By newseditor
Posted 28 May
Emerging paradigms and rece…
By newseditor
Posted 28 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar